Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct;12(10):405-410.
doi: 10.14740/jmc3742. Epub 2021 Sep 29.

A Rare Case of Pulmonary-Renal Syndrome With Triple-Seropositive for Myeloperoxidase-Anti-Neutrophil Cytoplasm Antibody (MPO-ANCA), Proteinase 3 (PR3)-ANCA and Anti-Glomerular Basement Membrane (GBM) Antibodies

Affiliations
Case Reports

A Rare Case of Pulmonary-Renal Syndrome With Triple-Seropositive for Myeloperoxidase-Anti-Neutrophil Cytoplasm Antibody (MPO-ANCA), Proteinase 3 (PR3)-ANCA and Anti-Glomerular Basement Membrane (GBM) Antibodies

Vanessa Palha et al. J Med Cases. 2021 Oct.

Abstract

Anti-glomerular basement membrane (anti-GBM) disease and anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis are the main causes of pulmonary-renal syndrome (PRS). The concurrence of both ANCA - myeloperoxidase (MPO) and proteinase 3 (PR3) - and anti-GBM antibodies has been described, although positivity for all three antibodies has rarely been reported. The natural history of triple-positive patients as well as the best therapeutic approach remains unknown. We describe a case of an 80-year-old woman that presented to the emergency department with a 3-month history of progressive fatigue, malaise and anorexia, and 5 weeks of cough with blood-streaked sputum and progressive peripheral edema. Through the complementary study, a rare diagnosis of PRS with triple-seropositive for both ANCA (MPO and PR3) and anti-GBM antibodies was made in a patient with untreated chronic hepatitis B virus infection. She was treated with glucocorticoid, cyclophosphamide, plasma exchange and entecavir, with pulmonary recovery. Renal function did not improve. After 2 years, the patient is still in dialysis, but did not have relapse of alveolar hemorrhage and ANCA and anti-GBM antibody titers remain negative. The authors intend to warn to PRS, in particular this rare cause, since delaying diagnosis can lead to significant morbidity and mortality for patients.

Keywords: Anti-membrane basal glomerular antibody; Anti-neutrophil cytoplasmic antibodies; Diffuse alveolar hemorrhage; Hepatitis B; Pulmonary-renal syndrome; Rapidly progressive glomerulonephritis; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

Figure 1
Figure 1
Thorax CT scan (a, b) and chest X-ray (c) showing bilateral diffuse infiltrates of the lung. CT: computed tomography.
Figure 2
Figure 2
Kidney biopsy findings. Photomicrograph showing (a) three glomeruli with cellular crescents, associated with mildly interstitial fibrosis and moderate inflammatory infiltrate (H&E, × 100); (b) glomerulus with a cellular crescent (Masson’s trichrome, × 400); (c) Jones methenamine silver staining delineating glomerular and tubular basement, also showing a cellular crescent (× 400); (d) immunofluorescence staining revealing strong linear immunoglobulin G (3+) along the glomerular basement membrane. H&E: hematoxylin and eosin.

Similar articles

Cited by

References

    1. West SC, Arulkumaran N, Ind PW, Pusey CD. Pulmonary-renal syndrome: a life threatening but treatable condition. Postgrad Med J. 2013;89(1051):274–283. doi: 10.1136/postgradmedj-2012-131416. - DOI - PubMed
    1. Omotoso BA, Cathro HP, Balogun RA. Crescentic glomerulonephritis with dual positive anti-GBM and C-ANCA/PR3 antibodies. Clin Nephrol Case Stud. 2016;4:5–10. doi: 10.5414/CNCS108666. - DOI - PMC - PubMed
    1. McAdoo SP, Tanna A, Hruskova Z, Holm L, Weiner M, Arulkumaran N, Kang A. et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017;92(3):693–702. doi: 10.1016/j.kint.2017.03.014. - DOI - PMC - PubMed
    1. Canney M, Little MA. ANCA in anti-GBM disease: moving beyond a one-dimensional clinical phenotype. Kidney Int. 2017;92(3):544–546. doi: 10.1016/j.kint.2017.04.024. - DOI - PubMed
    1. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12(7):1162–1172. doi: 10.2215/CJN.01380217. - DOI - PMC - PubMed

Publication types

LinkOut - more resources